הזדמנות עסקית | בריטניה  | 96677 | שיתוף פעולה | כימיה, רפואה ופרמצבטיקה | 21/02/2019

Blood Tests

הזדמנות עסקית זאת היא בת למעלה מחצי שנה מומלץ לבדוק האם היא עדיין בתוקף

A British company that has two prospective products (patent-pending), would like to trial in Israel. They are blood tests that detect rare anaemias and sickle cell mutations much faster than current genome sequencing methods. 

They are immediately seeking an established company in Israel with any links to hospitals / GPs / clinics / haematology departments.
The ideal partner would be a company who already provide products or services to any of these stakeholders.

The company is also in the process of applying for product development funding from Innovate UK and need an Israeli partner to be eligible. 

Basic facts about the company:

  • Established in 1994 (spin-out from ICI Advanced Materials)
  • >250 person years specialist microengineering experience
  • >200 satisfied customers
  • >£5m of asset investment
  • ~£1million income, profitable, no debt
  • 15 (inc. 5 part time & 2 PhDs) direct employees, indirect ~x3 via collaborative projects
  • Strategy – solution provision to production
  • Extensive support networks
  • Strong University links (mainly UK - currently 1 KTP, 1 Marie Curie ITN, 6 PhD studentships)
  • DTI, Innovate UK, EU frameworks service contract, project management & participation experience

Applications: biology in microfluidic flow and at surfaces sorting, concentrating, cell lysing, identification.

 

 

פרטים על ההזדמנות

בריטניה 
  • Country:
    United Kingdom
  • Number:
    96677
  • Activity:
    Joint Ventures
  • Branch:
    Chemistry, Medicine, Pharmaceuticals and Cosmetics
  • Published:
    21/02/2019
Member of trade organization, association or chamber of commerce :
Change the CAPTCHA code

חדשות חמות